On the recordOctober 6, 2015
This is an incredibly expensive endeavor and a good example of how research could slow the progression of the disease or help develop more cost-effective treatments for those with kidney disease.
Source
congress.govRoy Blunt: “This is an incredibly expensive endeavor and a good example of how research could slow the progression of the disease or…”
Editor's note · Context
Roy Blunt highlights the financial burden of kidney disease and the potential of research for cost-effective treatments.
Share
More from Roy Blunt
Dec 18, 2022
I have been Chairman twice--let's see, I was Chairman, then Senator Shelby was Chairman, then I was Chairman again.
Dec 5, 2023
Senator Blunt's longstanding promise of expanding the reach and resources of the Nation's Registry has saved thousands of lives.
Dec 6, 2023
Please continue this commitment and provide timely investments public health and research programs at the CDC and in the NIH.
Sep 26, 2022
Through the strong, bipartisan action of this Subcommittee's leaders, Chairman Roy Blunt and Ranking Member Patty Murray, Congress is helping the agency regain lost ground after years of effectively flat budgets.
Other voices in this conversation
